| Dr Jeremy Sean Deherrera, DC | |
|
1643 24th St W, Ste 203, Billings, MT 59102-2677 | |
| (406) 652-5140 | |
| (406) 294-2822 |
| Full Name | Dr Jeremy Sean Deherrera |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 10 Years |
| Location | 1643 24th St W, Billings, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306240080 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | CHI-CHI-LIC-3416 (Montana) | Primary |
| Provider Name | Back In Motion Chiropractic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1033513791 PECOS PAC ID: 5092936336 Enrollment ID: O20141029002410 |
News Archive
The Marshall University Joan C. Edwards School of Medicine has launched its first scholarly medical journal. The Marshall Journal of Medicine is a peer-reviewed, open-access online journal designed to shed light on medical issues and conditions of priority to West Virginians and the Appalachian region.
In a move that promises to expand the clinical testing of another promising malaria vaccine candidate, the US-based PATH Malaria Vaccine Initiative (MVI) and the Chinese company Shanghai Wanxing Bio-Pharmaceuticals today announced an agreement that supports the development of a pediatric malaria vaccine against Plasmodium (P.) falciparum, the most deadly strain of malaria.
Scientists and health officials are increasing efforts to curb a drug-resistant malaria strain along the Thai-Cambodian border that is becoming increasingly resistant to artemisinin, an ingredient in artemisinin-based combination therapies, IRIN News reports.
DBV Technologies (DBV), a biotech company specializing in food allergy with innovative products for diagnosis and treatment, announced today the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application. DBV Technologies will begin clinical investigation of its lead food allergy desensitization candidate, VIASKIN® PEANUT, for the desensitization to peanut allergy. The Company expects to commence recruitment of peanut allergy patients at several medical centers in the U.S. this month.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeremy Sean Deherrera, DC 1643 24th St W, Ste 203, Billings, MT 59102-2677 Ph: (406) 652-5140 | Dr Jeremy Sean Deherrera, DC 1643 24th St W, Ste 203, Billings, MT 59102-2677 Ph: (406) 652-5140 |
News Archive
The Marshall University Joan C. Edwards School of Medicine has launched its first scholarly medical journal. The Marshall Journal of Medicine is a peer-reviewed, open-access online journal designed to shed light on medical issues and conditions of priority to West Virginians and the Appalachian region.
In a move that promises to expand the clinical testing of another promising malaria vaccine candidate, the US-based PATH Malaria Vaccine Initiative (MVI) and the Chinese company Shanghai Wanxing Bio-Pharmaceuticals today announced an agreement that supports the development of a pediatric malaria vaccine against Plasmodium (P.) falciparum, the most deadly strain of malaria.
Scientists and health officials are increasing efforts to curb a drug-resistant malaria strain along the Thai-Cambodian border that is becoming increasingly resistant to artemisinin, an ingredient in artemisinin-based combination therapies, IRIN News reports.
DBV Technologies (DBV), a biotech company specializing in food allergy with innovative products for diagnosis and treatment, announced today the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application. DBV Technologies will begin clinical investigation of its lead food allergy desensitization candidate, VIASKIN® PEANUT, for the desensitization to peanut allergy. The Company expects to commence recruitment of peanut allergy patients at several medical centers in the U.S. this month.
› Verified 8 days ago
Billings Family Chiropractic, Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 1643 24th St W, Suite 203, Billings, MT 59102 Phone: 406-294-2820 Fax: 406-294-2822 | |
Hultgren Chiropractors Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 944 Ave B, Billings, MT 59102 Phone: 406-259-1250 Fax: 406-259-5043 | |
Dr. Mark Jonathan Haynes, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 670 King Park Dr, Ste 1, Billings, MT 59102 Phone: 406-655-4940 Fax: 406-655-4944 | |
Dr. Ryan Allan Oblander, DC, MS Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 3307 Grand Ave Ste 101, Billings, MT 59102 Phone: 140-665-2355 | |
Dr. Vernon Trent Jenkins, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2860 Old Hardin Rd Suite Aa, Billings, MT 59101 Phone: 406-245-0282 | |
Back In Motion Chiropractic Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 1643 24th St W Ste 203, Billings, MT 59102 Phone: 406-652-5140 Fax: 406-294-2822 | |
Back Country Family Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3202 Henesta Dr, Suite D, Billings, MT 59102 Phone: 406-294-5294 |